Omnicell
OMCL
35.21
-0.25
-0.71%
Omnicell
US · OMCL
#2961 by market cap
Listed 1970
35.21
-0.25
-0.71%
Live - 5344 symbols - heartbeat 426s ago
· 2026-10-08 01:50
After-hours
35.21
0.00%
Overnight
35.23
+0.06%
- Market cap
- 1.61B
- P/E (TTM)i
- 41.92
- P/Bi
- 1.24
- EPSi
- 0.04
- Div yieldi
- 0.00%
- 52W posi
- 24%
Reader sentiment
Are you bullish or bearish on OMCL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.30, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.53% YoY
Margins
- Gross margin
- 42.49%
- Operating margin
- 0.44%
- Net margin
- 0.17%
Key ratios & quality
- Enterprise valuei
- 1.57B
- Altman Z-Scorei
- 2.30
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 787.31M | 897.03M | 892.21M | 1.13B | 1.30B | 1.15B | 1.11B | 1.18B |
| Gross profit | 372.33M | 436.91M | 413.29M | 554.65M | 588.99M | 496.84M | 471.00M | 503.44M |
| Selling & admin expenses | 263.10M | 289.92M | 307.61M | 389.43M | 486.34M | 434.59M | 380.25M | 409.61M |
| Research & development | 64.84M | 68.64M | 70.16M | 75.72M | 104.97M | 97.12M | 90.41M | 88.67M |
| Operating profit | 44.39M | 78.35M | 35.53M | 89.51M | -2.32M | -34.87M | 337.00K | 5.16M |
| Pretax profit | 35.62M | 73.93M | 29.35M | 66.01M | -2.45M | -20.11M | 25.59M | 11.33M |
| Tax | -2.11M | 12.60M | -2.85M | -11.84M | -8.10M | 263.00K | 13.06M | 9.27M |
| Net profit | 37.73M | 61.34M | 32.19M | 77.85M | 5.65M | -20.37M | 12.53M | 2.05M |
| Basic EPS | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.93 | 1.43 | 0.74 | 1.62 | 0.12 | -0.45 | 0.27 | 0.04 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 269.67M | 290.56M | 310.63M | 313.98M | 309.88M | 312.21M |
| Gross profit | 110.94M | 127.68M | 134.50M | 130.33M | 140.36M | 152.94M |
| Selling & admin expenses | 102.03M | 97.99M | 102.24M | 107.36M | 101.99M | 100.19M |
| Research & development | 20.53M | 21.57M | 24.02M | 22.55M | 21.52M | 20.30M |
| Operating profit | -11.62M | 8.12M | 8.24M | 415.00K | 16.85M | 32.45M |
| Pretax profit | -9.53M | 10.45M | 9.70M | 699.00K | 16.91M | 33.83M |
| Tax | -2.51M | 4.81M | 4.24M | 2.73M | 5.55M | 9.54M |
| Net profit | -7.02M | 5.64M | 5.46M | -2.03M | 11.36M | 24.29M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | -0.15 | 0.12 | 0.12 | -0.05 | 0.25 | 0.52 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 397.13M | 483.24M | 829.41M | 780.70M | 881.81M | 927.57M | 815.49M | 680.07M |
| Cash & ST investments | 67.19M | 136.98M | 496.17M | 359.72M | 341.85M | 479.84M | 381.68M | 211.17M |
| Inventory | 100.87M | 108.01M | 96.30M | 119.92M | 147.55M | 110.10M | 88.66M | 100.91M |
| Total assets | 1.08B | 1.24B | 1.82B | 2.14B | 2.21B | 2.23B | 2.12B | 1.97B |
| Total current liabilities | 204.58M | 237.00M | 276.42M | 876.16M | 428.45M | 367.79M | 595.68M | 476.61M |
| Short-term debt | -- | 10.06M | 12.20M | 501.10M | 10.76M | 10.52M | 185.03M | 11.96M |
| Long-term debt | 135.42M | 50.00M | 467.20M | -- | 566.57M | 569.66M | 166.40M | 167.60M |
| Total liabilities | 401,625,000.00 | 395,556,000.00 | 857,001,000.00 | 995,807,000.00 | 1,080,621,000.00 | 1,037,924,000.00 | 877,647,000.00 | 742,906,000.00 |
| Total equity | 679.62M | 845.25M | 967.50M | 1.15B | 1.13B | 1.19B | 1.24B | 1.23B |
| Retained earnings | 197.45M | 258.79M | 290.72M | 368.57M | 390.73M | 370.36M | 382.89M | 384.94M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 839.67M | 844.78M | 659.62M | 680.07M | 722.30M | 735.39M |
| Cash & ST investments | 399.43M | 411.63M | 193.45M | 211.17M | 253.64M | 307.01M |
| Inventory | 91.14M | 105.78M | 107.43M | 100.91M | 99.20M | 96.72M |
| Total assets | 2.15B | 2.15B | 1.95B | 1.97B | 2.00B | 2.00B |
| Total current liabilities | 607.53M | 594.39M | 456.59M | 476.61M | 483.05M | 447.44M |
| Short-term debt | 186.11M | 186.66M | 11.89M | 11.96M | 11.62M | 11.49M |
| Long-term debt | 166.70M | 166.99M | 167.29M | 167.60M | 167.90M | 168.20M |
| Total liabilities | 894,370,000.00 | 881,877,000.00 | 727,695,000.00 | 742,906,000.00 | 747,476,000.00 | 707,254,000.00 |
| Total equity | 1.26B | 1.26B | 1.22B | 1.23B | 1.26B | 1.29B |
| Retained earnings | 375.87M | 381.50M | 386.97M | 384.94M | 396.30M | 420.59M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 103.97M | 145.01M | 185.87M | 231.81M | 77.78M | 181.09M | 187.72M | 127.30M |
| Depreciation & amortization | 51.35M | 64.12M | 71.60M | 84.93M | 99.17M | 95.56M | 89.76M | 86.63M |
| Free cash flow | 49.59M | 83.34M | 131.00M | 173.47M | 17.04M | 126.08M | 134.93M | 69.37M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 39.57M | 37.81M | -53.04M | 0 | -52.21M | 0 | 0 | -77.60M |
| Ending cash balance | 67.19M | 127.21M | 489.92M | 355.62M | 352.84M | 500.98M | 398.61M | 251.03M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 25.92M | 42.76M | 28.27M | 30.35M | 54.50M | 68.31M |
| Depreciation & amortization | 21.84M | 21.65M | 21.37M | 21.78M | 20.50M | 20.75M |
| Free cash flow | 10.19M | 26.83M | 13.99M | 18.36M | 38.63M | 55.78M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -61.95M | 0 | -- | -- |
| Ending cash balance | 414.40M | 431.50M | 225.46M | 251.03M | 290.97M | 322.75M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 6.30 | 8.05 | 3.55 | 7.36 | 0.50 | -1.76 | 1.03 | 0.17 |
| ROA %i | 3.66 | 5.28 | 2.10 | 3.92 | 0.26 | -0.92 | 0.58 | 0.10 |
| ROIC %i | 4.94 | 6.89 | 2.63 | 4.89 | 0.33 | -1.15 | 0.73 | 0.13 |
| 5-year avg ROE %i | 6.13 | 6.09 | 5.25 | 6.25 | 5.11 | 3.54 | 2.14 | 1.46 |
| EBIT margin %i | 5.64 | 8.73 | 3.98 | 7.91 | -0.18 | -3.04 | 0.03 | 0.44 |
| FCF / sales %i | 6.30 | 9.29 | 14.68 | 15.32 | 1.31 | 10.99 | 12.13 | 5.85 |
| Current ratioi | 1.94 | 2.04 | 3.00 | 0.89 | 2.06 | 2.52 | 1.37 | 1.43 |
| Quick ratioi | 1.29 | 1.50 | 2.48 | 0.69 | 1.50 | 1.99 | 1.07 | 0.90 |
| Debt / assetsi | 12.52 | 8.92 | 28.96 | 25.25 | 27.90 | 27.58 | 18.04 | 10.35 |
| LT debt / equityi | 19.93 | 11.91 | 53.34 | 3.48 | 53.62 | 50.77 | 15.89 | 15.62 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 17.56 | 8.83 | 7.77 | 12.87 | 13.05 | 8.74 | -0.59 | -2.94 |
| Net income CAGR (3Y) %i | 7.04 | 84.57 | 1.80 | 27.31 | -54.84 | -- | -45.60 | -28.64 |
| FCF CAGR (3Y) %i | 39.17 | 59.00 | -- | 51.80 | -41.09 | -1.27 | -8.03 | 59.67 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 1.73 | 1.87 | 1.62 | 0.17 | 1.63 | 3.06 |
| ROA %i | 0.96 | 1.04 | 0.94 | 0.10 | 0.98 | 1.89 |
| ROIC %i | 1.23 | 1.33 | 1.22 | 0.13 | 1.32 | 2.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 0.93 | 1.35 | 1.46 | 0.44 | 2.75 | 4.65 |
| FCF / sales %i | 9.47 | 7.76 | 7.96 | 5.85 | 7.98 | 10.17 |
| Current ratioi | 1.38 | 1.42 | 1.44 | 1.43 | 1.50 | 1.64 |
| Quick ratioi | 1.07 | 1.08 | 0.96 | 0.90 | 1.04 | 1.19 |
| Debt / assetsi | 17.93 | 17.92 | 10.61 | 10.35 | 10.09 | 10.01 |
| LT debt / equityi | 15.89 | 15.65 | 15.96 | 15.62 | 15.16 | 14.60 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Connected devices, software licenses, and other is the largest reported line at 47.80% of revenue, across 4 reported segments.
- Software as a Service (SaaS) and Expert Services follows at 21.97%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Connected devices, software licenses, and other47.80%
Software as a Service (SaaS) and Expert Services21.97%
Technical Services21.96%
Consumables8.27%
Quote time 2026-10-08 01:50:51 · For reference only, not investment advice and not tailored to your situation.